255 related articles for article (PubMed ID: 19640206)
41. In vivo animal studies with gadolinium (III) texaphyrin as a radiation enhancer.
Miller RA; Woodburn K; Fan Q; Renschler MF; Sessler JL; Koutcher JA
Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):981-9. PubMed ID: 10571206
[TBL] [Abstract][Full Text] [Related]
42. [Whole brain radiation therapy for brain metastases: Advantages and controversies].
Noël G; Tallet A; Truc G; Bernier V; Feuvret L; Assouline A; Antoni D; Verrelle P; Mazeron JJ; Mornex F; Dhermain F
Cancer Radiother; 2015 Feb; 19(1):30-5. PubMed ID: 25662599
[TBL] [Abstract][Full Text] [Related]
43. Current role of radiation therapy in the management of malignant brain tumors.
Truong MT
Hematol Oncol Clin North Am; 2006 Apr; 20(2):431-53. PubMed ID: 16730301
[TBL] [Abstract][Full Text] [Related]
44. New radiosensitizing regimens, drugs, prodrugs, and candidates.
Vallerga AK; Zarling DA; Kinsella TJ
Clin Adv Hematol Oncol; 2004 Dec; 2(12):793-805. PubMed ID: 16166960
[TBL] [Abstract][Full Text] [Related]
45. [Electron acceptor compounds as radiation sensitizers of hypoxic cells in human tumors].
Kiseleva ES; Dar'ialova SL
Med Radiol (Mosk); 1984 Sep; 29(9):74-82. PubMed ID: 6384719
[No Abstract] [Full Text] [Related]
46. [Chemotherapy of metastatic brain tumors, with special reference to continuous intracranial infusion of mitomycin C and a radiosensitizer, BUdR].
Takakura K
Gan No Rinsho; 1971 Apr; 17(4):263-8. PubMed ID: 5108090
[No Abstract] [Full Text] [Related]
47. [Evidence based medicine in therapy of brain tumors].
Kortmann RD
Krankenpfl J; 2005; 43(7-10):231. PubMed ID: 16515301
[No Abstract] [Full Text] [Related]
48. Motexafin-gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a children's oncology group phase 2 study.
Bradley KA; Zhou T; McNall-Knapp RY; Jakacki RI; Levy AS; Vezina G; Pollack IF
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e55-60. PubMed ID: 23092726
[TBL] [Abstract][Full Text] [Related]
49. Radiotherapy for primary and secondary brain tumors.
Brada M; Ross G
Curr Opin Oncol; 1995 May; 7(3):214-9. PubMed ID: 7654822
[TBL] [Abstract][Full Text] [Related]
50. Combining radiotherapy with systemic therapies.
Vokes EE
Clin Adv Hematol Oncol; 2008 Mar; 6(3):167-9. PubMed ID: 18391914
[No Abstract] [Full Text] [Related]
51. Chemotherapy for malignant gliomas.
Kreisl TN
Semin Radiat Oncol; 2009 Jul; 19(3):150-4. PubMed ID: 19464629
[TBL] [Abstract][Full Text] [Related]
52. Motexafin gadolinium: a promising radiation sensitizer in brain metastasis.
Thomas SR; Khuntia D
Expert Opin Drug Discov; 2011 Feb; 6(2):195-203. PubMed ID: 22647136
[TBL] [Abstract][Full Text] [Related]
53. [Use of radiotherapy and chemotherapy in child cerebral tumors].
Daoud J; Frikha M
Tunis Med; 1997 Nov; 75(11):826-31. PubMed ID: 9507326
[No Abstract] [Full Text] [Related]
54. Chemotherapy for glioblastoma: is costly better?
Linz U
Cancer; 2008 Nov; 113(10):2617-22. PubMed ID: 18833584
[No Abstract] [Full Text] [Related]
55. New and emerging radiosensitizers and radioprotectors.
Spalding AC; Lawrence TS
Cancer Invest; 2006; 24(4):444-56. PubMed ID: 16777698
[TBL] [Abstract][Full Text] [Related]
56. Cerebral metastases--a therapeutic update.
Cavaliere R; Schiff D
Nat Clin Pract Neurol; 2006 Aug; 2(8):426-36. PubMed ID: 16932601
[TBL] [Abstract][Full Text] [Related]
57. Progress in the use of gadolinium for NCT.
Cerullo N; Bufalino D; Daquino G
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S157-60. PubMed ID: 19410468
[TBL] [Abstract][Full Text] [Related]
58. Response to motexafin gadolinium and ionizing radiation of experimental rat prostate and lung tumors.
Dehnad H; Kal HB; Stam T; Gademan IS; van Moorselaar RJ; van der Sanden BP
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):787-93. PubMed ID: 14529785
[TBL] [Abstract][Full Text] [Related]
59. Human central nervous system distribution of cis-diamminedichloroplatinum and use as a radiosensitizer in malignant brain tumors.
Stewart DJ; Leavens M; Maor M; Feun L; Luna M; Bonura J; Caprioli R; Loo TL; Benjamin RS
Cancer Res; 1982 Jun; 42(6):2474-9. PubMed ID: 6280860
[No Abstract] [Full Text] [Related]
60. [Analysis of clinical experience in the use of metronidazole as a radiosensitizer of tumors].
Goldobenko GV; Kherkheulidze ZSh; Shchebetenko IuE; Polotskiĭ BE
Med Radiol (Mosk); 1983 Jul; 28(7):70-6. PubMed ID: 6348460
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
